Cancer Drugs Become Top Selling Therapeutic Category In The World
This article was originally published in The Pink Sheet Daily
Lipid-lowering drugs remain top category in U.S., despite lower sales.
You may also be interested in...
Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.
Oncology, lipid lowering and respiratory drugs helped to fuel 7 percent sales growth in the global pharmaceutical market in 2006, IMS reports.
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications